PFAS in Water: What to Check

Concerned about PFAS in your water and a health problem? Ask for a check of the water records, diagnosis and legal rights.

See If You Qualify

Free · No obligation · About 2 minutes

Updated 19 sources

This may apply to you if

  • Gather reports for your water source and the dates you used it.
  • Keep diagnosis, treatment and authorized care records.
  • Ask which exposure proof, legal rules and personal time limit apply.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

Industrial facility beside an affected waterway (photo illustration)
Photo illustration

The short answer

What should I check for a PFAS water claim?
Ask for a check of your water records, diagnosis and legal rights. A test result alone does not prove a claim. [4]
Does the 3M water deal decide my injury claim?
No. The court approved a deal for defined public water systems. Ask which case or order applies to your own injury claim. [10]
Does a PFAS utility settlement pay each resident?
It does not set an injury payment for each person. Ask about your own claim and any real offer. Check written fees and costs. [10]
What should I ask about PFAS legal fees?
Ask whether the review has a charge. Get written fees and expense terms before hiring a firm. Ask what is due if no money is recovered. [12]

Who qualifies

Do you qualify?

  • Gather reports for your water source and the dates you used it.
  • Keep diagnosis, treatment and authorized care records.
  • Ask which exposure proof, legal rules and personal time limit apply.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Joseph J. Shearer · Division of Cancer Epidemiology and Genetics, National Cancer Institute · First-listed co-first author

Finding: The nested case-control study found a positive association between prediagnostic blood PFOA levels and renal cell carcinoma. It did not establish the cause of one person’s illness.

Shearer and colleagues: PFAS and renal cell carcinoma (opens in a new tab) · Sep 18, 2020 · Checked Oct 3, 2026

Richard M. Gergel · United States District Court for the District of South Carolina · United States district judge signing the cited approval

Finding: The court approved the 3M public-water-system class settlement in March 2024. It explained that the release did not purport to release individuals’ personal injury claims.

Gergel 3M public water systems final approval order (opens in a new tab) · Mar 29, 2024 · Checked Oct 3, 2026

U.S. Environmental Protection Agency · Publisher of proposed rule guidance

Finding: The May 2026 proposal would allow eligible public water systems to request more compliance time while retaining PFOA and PFOS limits. A proposal is distinct from a final rule.

EPA proposed PFOA/PFOS compliance extension (opens in a new tab) · Apr 21, 2026 · Checked Oct 3, 2026

The evidence and its limits

National Cancer Institute with collaborating CDC and Harvard researchers · Journal of the National Cancer Institute · 2021

Prediagnostic PFAS and renal cell carcinoma in PLCO

Design:
Case-control
Participants:
324 renal cell carcinoma cases and 324 matched controls with prediagnostic blood samples.
Finding:
Higher blood PFOA was positively associated with renal cell carcinoma.
Main limitation
Observational nested case-control analysis; no assigned PFAS exposure or proof of local water source or individual causation.

Read the source: Prediagnostic PFAS and renal cell carcinoma in PLCO (opens in a new tab) · Checked Oct 3, 2026

National Cancer Institute and collaborating Multiethnic Cohort researchers · Environment International · 2023

PFAS and renal cell carcinoma in the Multiethnic Cohort

Design:
Case-control
Participants:
428 renal cell carcinoma cases and 428 matched controls with prediagnostic blood samples.
Finding:
PFOA was not associated with renal cell carcinoma overall; some subgroup findings were suggestive.
Main limitation
Observational analysis of specific chemicals and groups; an overall null association does not prove zero personal risk, nor do subgroup findings establish one person’s cause.

Read the source: PFAS and renal cell carcinoma in the Multiethnic Cohort (opens in a new tab) · Checked Oct 3, 2026

International Agency for Research on Cancer, World Health Organization · 2023

IARC PFOA and PFOS cancer hazard evaluation

Design:
Agency review
Participants:
Evidence review by an international working group; no single patient enrollment count.
Finding:
PFOA is classified as carcinogenic to humans and PFOS as possibly carcinogenic.
Main limitation
A hazard classification does not quantify cancer risk at a particular dose or establish individual causation; PFOA human cancer evidence was limited.

Read the source: IARC PFOA and PFOS cancer hazard evaluation (opens in a new tab) · Checked Oct 3, 2026

What this stage means for you

The March 2024 3M court approval concerns public water systems. It does not set your individual injury payment or current case status. Ask for the order that applies to you.

What rules a case out

Not covered by this case

  • A PFAS result or nearby facility alone does not prove that the water caused your illness. A public-water-system agreement does not establish your personal injury claim or payment.

What it costs

Lawyer fees and case expenses
Ask for written terms.

Ask about the percentage, expense deductions and costs if no money is recovered.

Source: ABA Model Rule 1.5 fees · as of Oct 3, 2026

Medical record copies
Ask about any copying charge.

Covered medical copies may have reasonable copying or mailing charges. Search or retrieval charges are barred under HHS access guidance.

Source: HHS your medical records · as of Oct 3, 2026

What happens step by step

  1. Check water and care

    Ask for water results and discuss health concerns with your clinician.

    Source: EPA PFAS in private wells · as of Oct 3, 2026

  2. Review the legal facts

    Bring notices and dates; ask which claim and time limit apply.

    Source: SDNY how long do I have to file? · as of Oct 3, 2026

  3. Read the agreement

    Check written fees, expenses and record-sharing terms before hiring a firm.

    Source: ABA Model Rule 1.5 fees · as of Oct 3, 2026

  1. August 2026

    EPA Enforcement Action Against Brenntag Great Lakes

  2. August 2026

    EPA Enforcement Actions Filed Against AMVAC CAFO and Brenntag Great Lakes

  3. August 2026

    EPA Issues Penalties Against AMVAC CAFO and Brenntag Great Lakes

  4. September 2026

    EPA Lists $930,000 Penalty Against Colgate-Palmolive

  5. September 2026

    EPA Enforcement Case Against Colgate-Palmolive Includes $930,000 Penalty

  6. September 2026

    EPA Enforcement Record Shows $930,000 Penalty Tied to Colgate-Palmolive

Who may qualify?

If you drank water with PFAS and have a health concern, ask for a check of your water and care records. A test result or diagnosis alone does not prove a legal claim. Your exposure, the cause of harm and the law need an individual review.

PFAS are a group of man-made chemicals. PFOA and PFOS are two members of that group. Different chemicals and exposure levels matter when discussing health concerns. Ask which PFAS were measured instead of treating every result with the same label as the same exposure.

Prepare the addresses where you lived, worked or drank water and the dates you can confirm. Note whether the water came from a public system or a private well. Keep the full test report or notice, not just a cropped number from a map. Ask a lawyer which facts can support your claim and which records are still missing.

For a relative, ask what authority is needed to request care records or discuss a claim. A covered provider can explain the record request process and its exceptions. Bring any existing legal papers to the lawyer. Do not assume that being a family member answers every records or filing question.

What is happening in the case right now?

A court approved a 3M deal for public water systems in March 2024. That agreement is separate from an individual injury claim. Ask for the latest filing or order that applies to your own case.

Judge Richard M. Gergel approved the water-system class settlement in South Carolina. The court explained that the release did not purport to release individuals’ personal injury claims. That distinction does not prove that every resident has a valid injury case. Ask which defendant, court and claim fit your facts.

EPA announced a final drinking-water rule in April 2024. In May 2026, it announced proposed changes to compliance timing and some other PFAS rules. A proposal is different from a final change. Ask your water provider which requirements and notices apply to its system today.

What could I get?

A water-system settlement does not set a payment for each person who drank its water. Your own claim and any actual offer need a check. Ask what the offer covers and which fees or expenses would be deducted.

The 3M agreement addresses defined public water systems and their water-related costs. It is not a household injury payment schedule. Ask whether a form or deadline concerns the system, a property claim or an individual injury. Those are different questions; do not divide a headline settlement number by the number of local residents.

Keep bills and notes about treatment and changes in daily life. Ask which losses the law recognizes for your situation and how they would need to be proved. If you receive an agreement, ask who it binds and what rights it releases. Get the terms explained before using a possible payment to plan your finances.

What does it cost to get help?

Ask whether the first legal review has a charge. Get the fee and case expenses in writing before hiring a firm. Ask what you could owe if the claim does not recover money.

The ABA model rule calls for a signed written contingent-fee agreement. Its terms should explain the percentage, expense deductions and costs if the case fails. That model rule is not a price quote from a firm. Ask which state rules and contract terms apply to you.

Ask which records or expert work may cost money and who would pay those costs. Keep those answers with the agreement. Medical copies can carry reasonable copying or mailing charges under HHS guidance. Ask for the needed records rather than assuming every copy or legal service is free.

Is there a deadline?

Ask promptly which time limit applies to your own claim. Bring your water notices, residence dates and diagnosis records. A water-system payment deadline is not automatically your injury filing deadline.

Court guidance explains that time limits depend on the claim and the law. A date from another state or another person’s case may not apply to you. Tell the lawyer about any earlier filing, settlement or agreement. Ask what must happen before the applicable date.

Keep the date of a water sample separate from the date you received its report. Also note when a clinician diagnosed a condition and when you first learned of a possible exposure. These are facts to bring for review, not a way to calculate your own legal cutoff. Missing a utility-program date does not let a general page decide all of your legal options.

What should I do today?

Ask your water provider for available PFAS results and discuss health concerns with your clinician. Keep notices, full test reports and care records. Ask a lawyer about the claim and your time limit.

For a private well, contact your state health or environmental agency about testing and reducing exposure. EPA does not regulate private wells. Its guidance points to state-certified laboratories and appropriate water treatment. Ask which steps fit the chemicals and levels found in your water.

Not all filters address PFAS. If you consider a filter, check its PFAS-reduction certification and follow the maintenance instructions. Certification does not by itself guarantee water meets every new federal limit. Ask for advice about your actual test results before choosing a device.

Ask your clinician about the benefits and limits of a PFAS blood test. ATSDR says blood levels do not predict future health problems or provide treatment instructions. A test does not replace a diagnosis. Keep medical care decisions with your care team.

What happens after I check?

First gather the water and health facts you know. Then ask which records, legal issues and time limit need review. Read written fees and record-sharing terms before agreeing to representation.

Make a short timeline with one row for each address and the dates you were there. Put water reports beside the period they concern. Mark uncertain dates clearly instead of filling gaps with guesses. Ask whether more information is needed to connect a reported source with the water you used.

Ask who would review your information and who would represent you if you hire a firm. Ask what the next step requires and what it could cost. Before sharing detailed medical files, ask who receives them and how they will be used. Keep a copy of any agreement and do not assume a request for records means a payment has been approved.

What is the evidence?

Research links some PFAS with health concerns, but findings differ by chemical and study. PFOA has a cancer-hazard classification. That classification does not show that one water supply caused one person’s illness.

Joseph J. Shearer and colleagues studied blood samples from 324 kidney-cancer cases and 324 matched controls. They measured samples taken before diagnosis. Higher PFOA levels were associated with greater risk of renal cell carcinoma, a type of kidney cancer. This was an observational comparison, not an experiment assigning people contaminated water.

Jongeun Rhee and colleagues later studied 428 cases and 428 matched controls in a more diverse group. They found no overall association between PFOA and that cancer. Some subgroup findings were suggestive, and other chemicals had different results. The studies show why a single finding should not be treated as an answer for every person.

IARC classifies PFOA as carcinogenic to humans and PFOS as possibly carcinogenic. Its PFOA assessment combined animal and mechanistic evidence with limited human cancer evidence. The categories describe cancer hazards, not the risk at a particular dose. They do not classify every PFAS chemical as the same hazard.

Under the 2024 public-water-system rule, EPA set PFOA and PFOS limits at four parts per trillion each. Compliance is based on running annual averages at the sampling point. The May 2026 timing proposal would allow an extension request to 2031 while retaining those limits. These rules do not determine the cause of an individual illness or the deadline to file a lawsuit.

Questions people ask

Does living near a base prove my water had PFAS? No. Ask for tests that match the water source and time involved. Location alone cannot replace a check of your actual exposure and health history.

Do I have to buy a blood test to ask about a claim? Ask the lawyer what records are needed and the clinician whether testing is useful. A blood test cannot predict future illness or select a treatment. Do not treat it as a universal legal acceptance rule.

Sources

EPA explains water testing and the scope of its rules. ATSDR explains clinical and blood-test limits, while IARC evaluates cancer hazards. Original studies report findings and differences between groups. The water-system court order answers settlement-scope questions; it does not decide every reader’s injury claim.

How PFAS "Forever Chemicals" in Drinking Water Cause Cancer and Disease

Per- and polyfluoroalkyl substances (PFAS) are a class of synthetic fluorinated chemicals used in industrial processes, consumer products, and aqueous film-forming foam (AFFF) firefighting foam since the 1940s. Because the carbon-fluorine bond is one of the strongest in chemistry, PFAS do not break down in the environment or the human body — earning them the name "forever chemicals." When PFAS enter drinking water through industrial discharge, AFFF runoff, or contaminated groundwater, communities face decades of exposure through their tap water. Chronic ingestion causes progressive bioaccumulation in blood, liver, and kidneys, triggering a cascade of toxic mechanisms that have been linked to kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, pregnancy-induced hypertension, and immunosuppression.

Serum Protein Binding and Organ Bioaccumulation

PFOA and PFOS bind tightly to serum albumin and liver fatty acid-binding proteins, concentrating in the liver, kidney, and blood. Unlike most environmental toxicants that are excreted within days, PFOA has a half-life of approximately 3.5 years in human serum and PFOS approximately 5 years. This means even modest ongoing exposure through contaminated drinking water results in steadily increasing body burdens over years and decades — with no biological mechanism for clearance unless exposure ceases entirely.

Endocrine Disruption and Thyroid Hormone Interference

PFAS structurally mimic thyroid hormones and compete with them for binding sites on serum transport proteins, particularly transthyretin. This interference suppresses free T4 and T3 levels, alters thyroid-stimulating hormone feedback, and disrupts the hypothalamic-pituitary-thyroid axis. Epidemiological studies of contaminated communities — including the C8 Health Project in Parkersburg, West Virginia — found significantly elevated rates of thyroid disease among residents with high PFOA serum levels. The C8 Science Panel found a probable link between PFOA exposure and thyroid disease.

Immune System Suppression and Reduced Vaccine Response

PFAS exposure is associated with dose-dependent suppression of antibody production following vaccination. Studies of Faroese children — a cohort with high seafood-related PFAS exposure — found that each doubling of PFAS serum concentration was associated with a 25–50% reduction in vaccine antibody titers against diphtheria and tetanus. Similar findings have been replicated in adult cohorts. The mechanism involves PFAS interference with B-cell and T-cell signaling pathways. In 2022, the National Toxicology Program concluded that PFAS are an immune hazard to humans.

Carcinogenicity — Kidney and Testicular Cancer

PFOA was classified as a Group 1 carcinogen (carcinogenic to humans) by the International Agency for Research on Cancer in November 2023, based on sufficient evidence from human epidemiology. The C8 Science Panel established probable links between PFOA exposure and kidney cancer and testicular cancer in the Mid-Ohio Valley population. PFOA promotes tumor formation through multiple pathways including PPAR-alpha activation (liver), oxidative stress, DNA damage response inhibition, and suppression of tumor suppressor gene expression. These mechanisms are dose-dependent and consistent across multiple epidemiological cohorts.

Developmental Toxicity and In Utero Exposure

PFAS cross the placental barrier and accumulate in umbilical cord blood and breast milk, exposing fetuses and newborns to maternal body burdens accumulated over years. In utero PFAS exposure has been associated with reduced birth weight, altered immune development, accelerated puberty in girls, and neurodevelopmental effects. Animal studies demonstrate fetal lethality, growth retardation, and skeletal deformities at high doses. The developing endocrine and immune systems are particularly vulnerable to disruption during critical windows of fetal development when PFAS cannot be cleared.

  • Invisible Contamination — No Taste, No Odor: PFAS are odorless, colorless, and tasteless in water at concentrations far exceeding health thresholds. Communities in Parkersburg, West Virginia and Camp Lejeune, North Carolina consumed PFAS-contaminated water for decades without any sensory indication of contamination. Without systematic testing, residents have no means of detecting exposure. This invisibility meant that affected populations could not take protective action and continued to accumulate body burdens unknowingly.
  • Decades-Long Latency Before Diagnosis: Cancers linked to PFAS exposure — including kidney cancer and testicular cancer — typically have latency periods of 10 to 30 years from initial exposure to clinical diagnosis. This means residents exposed through contaminated municipal water in the 1980s and 1990s may only now be manifesting PFAS-related cancers. The long latency makes it difficult for individuals to connect their cancer to water contamination years or decades earlier, and complicates statute of limitations analysis.
  • Universal Exposure Through Drinking Water Infrastructure: Unlike occupational PFAS exposures limited to workers, contaminated municipal water systems expose entire communities — men, women, children, and infants — through drinking, cooking, bathing, and food preparation. EPA estimates that PFAS are detectable in drinking water serving over 200 million Americans. Populations near military bases, airports, and PFAS manufacturing facilities face the highest concentrations, but PFAS contamination has been detected in water systems across all 50 states.
  • Manufacturer Knowledge Predating Community Exposure: 3M's internal toxicology studies from 1975 documented that PFOS caused significant toxicity in animal models. DuPont's internal records from the 1960s acknowledged that C8 (PFOA) was toxic and bioaccumulative. Both companies continued manufacturing and selling PFAS products for decades without warning communities, regulators, or the public. The gap between manufacturers' internal knowledge and public disclosure — in some cases exceeding 30 years — is central to the mass tort claims.
  • The International Agency for Research on Cancer classified PFOA as a Group 1 carcinogen in November 2023, the highest classification indicating sufficient evidence of human carcinogenicity.
  • The C8 Science Panel — an independent panel of epidemiologists funded by DuPont's settlement — found probable links between PFOA exposure and kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, high cholesterol, and pregnancy-induced hypertension.
  • The National Toxicology Program concluded in 2022 that PFAS are an immune hazard to humans based on consistent evidence of suppressed vaccine antibody responses across multiple study populations.
  • The EPA finalized Maximum Contaminant Levels of 4 parts per trillion for PFOA and PFOS individually in April 2024 — acknowledging no safe level of exposure — after decades of less protective health advisories.
  • Multiple large epidemiological studies have demonstrated dose-response relationships between PFAS serum concentrations and cancer incidence, immune dysfunction, and thyroid disruption, supporting biological plausibility of causation.

The harm mechanisms established by the C8 Science Panel, IARC, NTP, and independent epidemiologists provide the scientific foundation for PFAS water contamination litigation. Plaintiffs diagnosed with kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, high cholesterol, or pregnancy-induced hypertension who consumed contaminated drinking water can establish general causation through the C8 probable link findings and IARC's Group 1 classification. Specific causation requires evidence of PFAS exposure through contaminated water systems and, where possible, serum PFAS testing to document body burden.

Kidney Cancer (Renal Cell Carcinoma)

Kidney cancer, mostly renal cell carcinoma (RCC), is one of the six injuries the plaintiffs' leadership is pursuing in the AFFF MDL (MDL 2873), according to the court's Case Management Order No. 35 (Aug. 15, 2025). In 2023 the International Agency for Research on Cancer (IARC) classified PFOA as carcinogenic to humans (Group 1), based on sufficient evidence in animals and strong mechanistic evidence, with limited evidence in humans for kidney and testicular cancer. A hazard classification does not measure the risk at a particular exposure level. Studies disagree: a National Cancer Institute nested case-control study (324 RCC cases and 324 matched controls; Journal of the National Cancer Institute, 2021) found higher blood PFOA was positively associated with RCC, while a 2023 NCI study in the Multiethnic Cohort (428 RCC cases and 428 matched controls; Environment International) found PFOA was not associated with RCC overall. These studies show associations; they do not show that PFAS caused any one person's cancer.

  • Blood in urine (hematuria) — often the first symptom
  • Persistent lower back or flank pain on one side
  • Unexplained weight loss of 10 or more pounds
  • Fatigue and general weakness
  • Low-grade fever not explained by infection
  • Swelling in the legs or ankles
  • Palpable mass in the abdomen or side (advanced disease)
  • PFAS-contaminated drinking water exposure
  • Smoking — independent risk multiplier
  • Obesity and high blood pressure
  • Family history of renal cell carcinoma or Von Hippel-Lindau disease
  • Occupational chemical exposure (trichloroethylene, cadmium)
  • Long-term dialysis for other kidney disease

Testicular Cancer

Testicular cancer is one of the six injuries the plaintiffs' leadership is pursuing in the AFFF MDL (MDL 2873), according to the court's Case Management Order No. 35 (Aug. 15, 2025). In 2023 the International Agency for Research on Cancer (IARC) classified PFOA as carcinogenic to humans (Group 1), with limited evidence in humans for kidney and testicular cancer, and PFOS as possibly carcinogenic to humans (Group 2B). A hazard classification does not measure the risk at a particular exposure level or show that PFAS caused any one person's cancer.

  • Painless lump or swelling in one testicle — most common first sign
  • Dull ache or feeling of heaviness in the scrotum
  • Breast tenderness or growth (gynecomastia from hormone-producing tumors)
  • Back pain or abdominal pain if cancer has spread to lymph nodes
  • Fluid collection in the scrotum
  • PFAS-contaminated drinking water or AFFF occupational exposure
  • Military service or firefighting at PFAS-contaminated installations
  • Undescended testicle (cryptorchidism) — independent risk factor
  • Family history of testicular cancer
  • Young male (age 15–35 peak risk)

Thyroid Disease and Thyroid Cancer

Thyroid disease — including hypothyroidism, hyperthyroidism, Hashimoto's thyroiditis, and thyroid cancer — is strongly linked to PFAS exposure through the disruption of thyroid hormone signaling. PFAS molecules structurally resemble thyroid hormones and compete with them at binding sites, interfering with the production, transport, and metabolism of thyroxine (T4) and triiodothyronine (T3). Research from the C8 Health Project, Mount Sinai School of Medicine, and multiple European cohort studies has documented elevated rates of thyroid disease in PFAS-exposed populations. Women are disproportionately affected by PFAS-related thyroid disease because the thyroid gland is more active in women and thyroid autoimmune conditions are more prevalent in the female population. A 2018 Mount Sinai study found that higher serum PFAS concentrations were associated with significantly elevated thyroid cancer risk. In MDL 2873, thyroid disease (diagnosed hypothyroidism or hyperthyroidism requiring medication) is a recognized personal injury category, as is thyroid cancer. Ulcerative colitis — an inflammatory bowel condition linked to PFOA exposure in C8 data — is also recognized.

  • Unexpected weight gain or difficulty losing weight (hypothyroidism)
  • Fatigue, brain fog, and cold sensitivity (hypothyroidism)
  • Rapid or irregular heartbeat and anxiety (hyperthyroidism)
  • Goiter — swelling or lump in the neck
  • Voice changes or difficulty swallowing (thyroid cancer)
  • Enlarged lymph nodes in the neck (thyroid cancer spread)
  • PFAS-contaminated drinking water exposure — thyroid disruption documented in multiple studies
  • Female sex — women are 3 times more likely to develop thyroid disease
  • History of radiation exposure to the neck
  • Family history of thyroid disorders or autoimmune disease
  • Iodine deficiency or excess (independent factor)

Who Is Most at Risk: PFAS Water Contamination Exposure Profiles

PFAS contamination of drinking water affects communities across the United States, but exposure intensity varies significantly based on proximity to contamination sources, duration of residence, and reliance on affected water systems. The following profiles identify the populations at greatest risk of PFAS-related health effects and the characteristics that define their exposure. All profiles assume chronic exposure through municipal or private well drinking water as the primary pathway.

Military Personnel and Veterans at AFFF-Using Bases

Combined occupational and residential — AFFF direct contact plus contaminated base drinking water

  • Living or working on military installations with AFFF-contaminated groundwater
  • Drinking water from base water systems drawing from PFAS-contaminated aquifers
  • Participation in or proximity to AFFF fire training exercises
  • Showering, cooking, and food preparation using base water supplies
  • Extended tours of duty (3–20+ years) at contaminated installations

Civilian Residents Near Contaminated Municipal Water Systems

Residential — long-term ingestion of PFAS-contaminated municipal drinking water

  • Drinking tap water from municipal systems drawing from PFAS-contaminated sources
  • Cooking with tap water (soups, pasta, coffee, baby formula preparation)
  • Brushing teeth and bathing with PFAS-contaminated water
  • Consuming locally grown produce irrigated with contaminated water
  • Residing in affected communities for 10 or more years

Firefighters with AFFF Occupational Exposure

Occupational — direct AFFF contact during firefighting and training plus residential water exposure

  • Using AFFF foam during structural fire suppression and petroleum fire response
  • Conducting fire training exercises at facilities where AFFF is applied to training areas
  • Skin contact with AFFF-contaminated equipment, gear, and surfaces
  • Cleaning AFFF foam from equipment without adequate protective equipment
  • Residing in communities where fire training sites have contaminated groundwater

Workers at PFAS Manufacturing Facilities

Occupational — workplace air and dermal PFAS exposure plus contaminated local water

  • Working in production, quality control, or maintenance roles at PFAS manufacturing plants
  • Inhalation of PFAS aerosols, dust, and fumes in production areas
  • Skin contact with PFAS process chemicals without adequate protective equipment
  • Consuming food and water in contaminated break areas or facility cafeterias
  • Residing in communities near manufacturing facilities with contaminated groundwater

Residents Near PFAS Industrial Sites and Landfills

Residential — contaminated private wells and groundwater near industrial discharge sites

  • Drinking water from private wells drawing from PFAS-contaminated aquifers
  • Using well water for all household purposes — cooking, bathing, irrigation
  • Living within a 5-mile radius of PFAS manufacturing plants, airports, or landfills receiving PFAS waste
  • Long-term residence with no alternative water supply
  • Limited or no knowledge of contamination due to lack of public notification

Exposure profiles are based on publicly available epidemiological research, C8 Science Panel findings, DoD contamination disclosures, and EPA data. Individual risk assessment requires evaluation of specific water system contamination levels, duration of residence, serum PFAS testing where available, and diagnosed health conditions. This information does not constitute medical or legal advice. Individuals who believe they have been exposed to PFAS-contaminated drinking water should consult a qualified attorney.

3M and DuPont's Decades of PFAS Concealment: What Corporate Records Reveal

The PFAS water contamination crisis is not an accident of unknowable science — it is the direct result of deliberate corporate decisions by 3M Company and DuPont de Nemours to manufacture and sell PFAS products while concealing internal evidence of their toxicity. Internal documents obtained through litigation discovery reveal that both companies possessed detailed knowledge of PFAS bioaccumulation, toxicity, and environmental persistence dating to the 1950s and 1960s — yet continued producing PFAS for decades while suppressing, minimizing, and failing to disclose that knowledge to regulators, workers, and the communities whose drinking water they contaminated.

Dark Waters, Congressional Investigations, and the C8 Science Panel

The PFAS contamination scandal became a defining case study in corporate environmental malfeasance. Attorney Robert Bilott's 20-year legal campaign against DuPont — chronicled in the 2019 film Dark Waters and Nathaniel Rich's New York Times Magazine investigation — exposed how DuPont's own scientists had flagged PFOA toxicity since the 1960s while the company discharged the chemical into communities' drinking water. Congressional investigations in 2019 and 2020 revealed that 3M and DuPont had shared internal PFAS health data with each other through industry groups while withholding it from regulators. The C8 Health Project — funded by DuPont's settlement — exposed 69,000 West Virginia and Ohio residents to PFAS monitoring and produced the most comprehensive epidemiological evidence of PFAS health effects available, ultimately establishing the six probable-link diseases that anchor personal injury litigation.

  • 2019 film Dark Waters (starring Mark Ruffalo as attorney Rob Bilott) brings PFAS contamination to national public attention and triggers surge in litigation inquiries
  • 2019–2020 congressional hearings reveal 3M and DuPont shared PFAS toxicology data internally through industry associations while withholding from EPA
  • Chemours Fayetteville Works facility in North Carolina found discharging GenX (HFPO-DA) into Cape Fear River — contaminating drinking water for Wilmington and surrounding communities
  • National Toxicology Program 2022 report concludes PFAS are an immune hazard to humans — contradicting decades of industry claims that PFAS were safe at real-world exposure levels

S&P Global

Downgrade Watch (3M, 2023)

Moody's

Baa1 with Negative Outlook (Chemours, 2022)

Cited PFAS remediation obligations, regulatory uncertainty, and GenX litigation as ongoing credit risks for Chemours following DuPont spinoff

Fitch

BBB with Stable Outlook (DuPont, 2023)

3M and DuPont possessed internal evidence of PFAS toxicity — including worker blood level anomalies, birth defects clusters, and animal tumor studies — for decades before taking protective action. The 70-year timeline from first PFAS synthesis to enforceable federal drinking water standards, and the billions in corporate settlements that have already been paid, establish that PFAS water contamination was a foreseeable and preventable harm caused by deliberate corporate decisions to prioritize profits over public health.

PFAS Regulatory Timeline: From Industry Self-Regulation to Federal Enforceable Standards

The regulatory history of PFAS reflects decades of industry resistance to government oversight, voluntary phaseouts that fell far short of protective action, and a slow accumulation of scientific consensus that ultimately compelled the EPA to issue the first enforceable federal drinking water standards for PFAS in April 2024. The 80-year gap between PFAS synthesis in the 1940s and binding federal regulation in 2024 — during which manufacturers concealed internal toxicology data — forms the core of plaintiffs' regulatory negligence and failure-to-warn claims.

The regulatory record demonstrates that 3M and DuPont possessed internal evidence of PFAS toxicity for decades before federal standards were enacted. The 2024 EPA MCL rule — setting a near-zero threshold of 4 ppt — confirms that any level of PFOA or PFOS in drinking water poses a meaningful cancer risk. The multi-billion-dollar water utility settlements establish corporate causation and ability to pay, while leaving the personal injury litigation track open for affected individuals.

PFAS Water Contamination Lawsuit Filing Deadlines

The statute of limitations for PFAS personal injury claims is typically 2 to 3 years from the date of a qualifying diagnosis — or from the date the claimant knew or reasonably should have known that their illness was caused by PFAS exposure. Because PFAS contamination was not widely publicized until 2016 (the Flint-era surge in water contamination coverage) and the EPA did not set enforceable maximum contaminant levels until April 2024, courts in many states have applied the discovery rule generously to PFAS claimants. MDL 2873 tolling agreements have also paused statutes of limitations for certain categories of claimants during the pendency of the MDL.

Discovery Rule and PFAS-Specific Tolling

PFAS personal injury claims are governed by the discovery rule in most states — the limitations clock begins when the claimant knew or should have known of both the injury and its likely PFAS cause. Because PFAS contamination sites were not publicly disclosed until DoD disclosure requirements took effect (post-2016), and because PFAS health effects were not broadly communicated to affected communities until 2018–2020, courts have been receptive to delayed discovery arguments for PFAS claimants with older diagnoses. Claimants who received cancer diagnoses from 2019 onward and who were not publicly informed of local PFAS contamination until DoD disclosures reached their community should consult an attorney about discovery rule arguments. MDL 2873 has also issued tolling orders that may extend deadlines for claimants who joined the MDL before certain cutoff dates. State-court PFAS claims not enrolled in the MDL are governed by their state's own limitations law without MDL tolling.

If you were diagnosed with kidney cancer, testicular cancer, thyroid disease, or ulcerative colitis and have reason to believe you were exposed to PFAS-contaminated water — especially near a military base — ask a PFAS litigation attorney to review your facts. Whether that time has passed depends on your facts, so don't rule yourself out. A lawyer can tell you.

Questions people ask

What are PFAS chemicals and why are they dangerous?

PFAS are widely used, long-lasting chemicals that break down very slowly over time. EPA says some PFAS are persistent in the environment and that studies have linked exposure to some PFAS with harmful health effects in humans and animals. Exposure alone does not prove why one person became sick.

Source: EPA: PFAS Explained · as of Oct 7, 2026

Who qualifies for a PFAS water contamination lawsuit?

It depends on your water source, exposure history, diagnosis, and deadline. EPA drinking-water rules and PFAS testing can help identify exposure, but they do not decide legal eligibility. A lawyer can review water data, medical records, and state law.

Source: EPA: PFAS National Primary Drinking Water Regulation · as of Oct 7, 2026

Is there a class action lawsuit for PFAS water contamination?

Not necessarily. Public water-system settlements are different from personal-injury claims by exposed people. A lawyer can check whether your facts involve a water provider, property, medical injury, or another claim type.

Source: Court-authorized 3M PFAS water-system settlement FAQ · as of Oct 7, 2026

How do I know if my drinking water has PFAS?

Start with your water provider, state environmental agency, or a certified water test. EPA says public water systems must meet federal PFAS drinking-water rules, while private-well owners may need to arrange their own testing. Save the test result and the address tied to the water source.

Source: EPA: PFAS in Private Wells · as of Oct 7, 2026

What is the statute of limitations for a PFAS lawsuit?

There is no single PFAS lawsuit deadline that applies to every situation. S.D.N.Y. says filing deadlines depend on the specific law or claim type, and state law may supply the deadline. A lawyer can check your exposure dates, diagnosis, water source, and state law.

Source: S.D.N.Y.: How long do I have to file my complaint? · as of Oct 7, 2026

What cancers are linked to PFAS exposure?

PFAS exposure does not prove why one person developed cancer. ATSDR says epidemiological evidence suggests associations between increased exposure to specific PFAS and kidney and testicular cancer, along with other health effects. A clinician and lawyer can review exposure history, water data, and medical records.

Source: ATSDR: How PFAS Impacts Your Health · as of Oct 7, 2026

Which records should I gather for a PFAS water contamination review?

Gather water test results, public-water notices, private-well records, addresses, dates of exposure, and medical records. EPA says public water systems must monitor for regulated PFAS and provide information to the public, and private-well owners may need their own testing information. These records do not prove a claim by themselves.

Source: EPA: PFAS National Primary Drinking Water Regulation · as of Oct 7, 2026

How does the deadline work for a PFAS water contamination question?

There is no one deadline for every PFAS water contamination question. S.D.N.Y. says filing deadlines depend on the law or type of claim, and state law may supply the deadline. A lawyer can check the rule that fits your exposure, injury, and state.

Source: S.D.N.Y.: How long do I have to file my complaint? · as of Oct 7, 2026

Stay informed

Get free updates about PFAS in Water: What to Check

No phone call required. We will email you when there is a relevant update.

By submitting, you agree to receive email updates about this case. You can unsubscribe anytime. This is not legal advice, and we are not a law firm.

Sources

  1. EPA PFAS drinking-water regulationEPA PFAS drinking-water regulation · regulator
  2. EPA proposed PFOA/PFOS compliance extensionEPA proposed PFOA/PFOS compliance extension · regulator
  3. EPA proposed PFAS rescission ruleEPA proposed PFAS rescission rule · regulator
  4. EPA PFAS in private wellsEPA PFAS in private wells · regulator
  5. ATSDR PFAS information for cliniciansATSDR PFAS information for clinicians · regulator
  6. ATSDR testing for PFASATSDR testing for PFAS · regulator
  7. IARC PFOA/PFOS evaluation Q&AIARC PFOA/PFOS evaluation Q&A
  8. Shearer and colleagues: PFAS and renal cell carcinomaShearer and colleagues: PFAS and renal cell carcinoma · study
  9. Rhee and colleagues: PFAS and renal cell carcinoma in Multiethnic CohortRhee and colleagues: PFAS and renal cell carcinoma in Multiethnic Cohort · study
  10. Gergel 3M public water systems final approval orderGergel 3M public water systems final approval order · court
  11. Court-authorized 3M water-system settlement FAQCourt-authorized 3M water-system settlement FAQ · court
  12. ABA Model Rule 1.5 feesABA Model Rule 1.5 fees
  13. HHS your medical recordsHHS your medical records · regulator
  14. SDNY how long do I have to file?SDNY how long do I have to file? · court
  15. EPA Issues $3.125M Consent Decree Against WTG Gas Processingecho.epa.gov · Jun 21, 2026 · regulator
  16. Study Finds PFAS in Kidney Tissue Linked to Doubled Transplant Risk; EPA Issues $1.2M Finepubmed.ncbi.nlm.nih.gov · Jul 9, 2026 · study
  17. Personal-injury track status: by Case Management Order No. 35 (Aug. 15, 2025), Judge Richard M. Gergel vacated the bellwether trial set for October 20, 2025, and all related dates in CMO 26-I, citing a large number of unfiled cases, and opened a 21-day Filing Facilitation Window for personal-injury cases alleging one of the six listed injuries (kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, liver cancer and thyroid cancer). The JPML reported 15,264 actions pending in MDL 2873 on October 1, 2026; that count covers all actions in the MDL.scd.uscourts.gov · Aug 15, 2025 · court
  18. Judge Gergel (D.S.C., AFFF MDL-2873) granted final approval of 3M's public water supplier settlement: $10.3B pre-tax present value, up to $12.5B nominal, paid over 13 years starting Q3 2024, covering U.S. public water suppliers that have detected or may detect PFAS. Verified via 3M's official press release.investors.3m.com · Mar 29, 2024
  19. Chemours, DuPont and Corteva announced a $1.185B settlement fund resolving PFAS drinking-water claims of a defined class of U.S. public water systems (Chemours ~$592M, DuPont ~$400M, Corteva ~$193M), subject to D.S.C. court approval in AFFF MDL-2873; excludes state/federally owned systems and most lower Cape Fear Basin systems. Verified via DuPont's official press release. (Final court approval followed in Feb 2024 per SEC filings — approval date not independently fetched.)dupont.com · Jun 2, 2023

Checked against 16 primary sources by People's Justice editors · Updated

How we make money

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest